These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30851694)

  • 1. β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma.
    Ling Y; Gao WJ; Ling C; Liu J; Meng C; Qian J; Liu S; Gan H; Wu H; Tao J; Dai H; Zhang Y
    Eur J Med Chem; 2019 Apr; 168():515-526. PubMed ID: 30851694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways.
    Ling Y; Li Y; Zhu R; Qian J; Liu J; Gao W; Meng C; Miao J; Xiong B; Qiu X; Ling C; Dai H; Zhang Y
    J Nat Prod; 2019 Jun; 82(6):1442-1450. PubMed ID: 31120744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.
    Ling Y; Guo J; Yang Q; Zhu P; Miao J; Gao W; Peng Y; Yang J; Xu K; Xiong B; Liu G; Tao J; Luo L; Zhu Q; Zhang Y
    Eur J Med Chem; 2018 Jan; 144():398-409. PubMed ID: 29288941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
    Li Y; Yan W; Yang J; Yang Z; Hu M; Bai P; Tang M; Chen L
    Eur J Med Chem; 2018 May; 152():516-526. PubMed ID: 29754076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities.
    Ding J; Liu J; Zhang Z; Guo J; Cheng M; Wan Y; Wang R; Fang Y; Guan Z; Jin Y; Xie SS
    Bioorg Chem; 2020 Aug; 101():104023. PubMed ID: 32650178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
    Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
    Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
    Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro biological evaluation of hybrids from tetrahydro-β-carboline and hydroxylcinnamic acid as antitumor carcinoma agents.
    Lin Y; Xia X; Yao R; Ni L; Hu J; Guo W; Zhu B
    Chem Pharm Bull (Tokyo); 2014; 62(4):343-9. PubMed ID: 24695344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway.
    Ling Y; Xu C; Luo L; Cao J; Feng J; Xue Y; Zhu Q; Ju C; Li F; Zhang Y; Zhang Y; Ling X
    J Med Chem; 2015 Dec; 58(23):9214-27. PubMed ID: 26555243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
    Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects.
    Tian C; Huang S; Xu Z; Liu W; Li D; Liu M; Zhu C; Wu L; Jiang X; Ding H; Zhao Q
    Bioorg Med Chem Lett; 2022 May; 64():128663. PubMed ID: 35272009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of C3-Substituted β-Carboline-Based Histone Deacetylase Inhibitors with Potent Antitumor Activities.
    Ling Y; Feng J; Luo L; Guo J; Peng Y; Wang T; Ge X; Xu Q; Wang X; Dai H; Zhang Y
    ChemMedChem; 2017 May; 12(9):646-651. PubMed ID: 28425177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
    Bai B; Li XY; Liu L; Li Y; Zhu HJ
    Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Hybrid CHC from β-carboline and
    Miao J; Meng C; Wu H; Shan W; Wang H; Ling C; Zhang J; Yang T
    Front Pharmacol; 2020; 11():626065. PubMed ID: 33536926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.
    Li X; Hou J; Li X; Jiang Y; Liu X; Mu W; Jin Y; Zhang Y; Xu W
    Eur J Med Chem; 2015 Jan; 89():628-37. PubMed ID: 25462271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of some β-carboline derivatives as multi-target anticancer agents.
    Abdelsalam MA; AboulWafa OM; Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N
    Future Med Chem; 2018 Dec; 10(24):2791-2814. PubMed ID: 30539666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
    Ahmed NM; Youns M; Soltan MK; Said AM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents.
    Barbosa VA; Baréa P; Mazia RS; Ueda-Nakamura T; Costa WFD; Foglio MA; Goes Ruiz ALT; Carvalho JE; Vendramini-Costa DB; Nakamura CV; Sarragiotto MH
    Eur J Med Chem; 2016 Nov; 124():1093-1104. PubMed ID: 27792980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
    Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
    Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
    Xie R; Li Y; Tang P; Yuan Q
    Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.